Supraventricular tachycardia (SVT) affects roughly 2.25 out of every 1,000 people, making it one of the more common heart rhythm disorders. While that number might sound small, it translates to hundreds of thousands of people living with episodes of rapid heartbeat that start above the heart’s lower chambers. In 2019 alone, nearly 140,000 emergency department visits in the United States had SVT as the primary diagnosis, and that number has been trending upward among adults.
Overall Prevalence
At a rate of about 2.25 per 1,000 people, SVT is common enough that most cardiologists and emergency physicians see it regularly. It’s not as widespread as atrial fibrillation, but it’s far from rare. The condition tends to come and go in episodes, so many people live with it for years, experiencing bursts of rapid heart rate that last minutes to hours before resolving on their own or with intervention.
The roughly 140,000 ER visits recorded in 2019 likely undercount the true burden, since many episodes end before someone reaches the hospital. A broader analysis that included SVT listed as a secondary diagnosis estimated closer to 260,000 ER visits that year. About 24% of those visits led to hospital admission, and another 10% resulted in an observation stay, meaning most people were evaluated and sent home the same day.
Who Gets SVT: Gender and Age
Women develop SVT about twice as often as men across all age groups. This isn’t evenly distributed across subtypes, though. The most common form, where the electrical signal loops within the heart’s central relay node, accounts for roughly half of all SVT cases and disproportionately affects women. Women with this type also tend to develop symptoms at a younger age than men do.
One exception to the female pattern involves a type of SVT caused by an extra electrical pathway between the upper and lower chambers of the heart. This form occurs more frequently in men. Wolff-Parkinson-White syndrome, the best-known version of this extra-pathway problem, accounts for about 2.4% of patients who show up to the emergency department with a fast, narrow-complex heart rhythm.
SVT in Children
A national birth cohort study tracking nearly 2 million live births found that SVT occurs at a rate of about 1 per 1,000 children per year by age 15. The condition can appear remarkably early. By one month of age, the cumulative incidence was 0.06 per 1,000; by one year, it reached 0.25 per 1,000. The rate climbs steadily through childhood, reaching 0.88 per 1,000 by age 10.
Boys and girls were affected almost equally in the pediatric data, with boys making up 51.6% of cases. That’s a notable contrast to the strong female predominance seen in adults. Children with major congenital heart defects or cardiomyopathy had significantly higher risks, but for children without these conditions, the overall numbers were only slightly lower. The risk of death from pediatric SVT was very low: 0.13% per year, with sudden death accounting for just 0.01% per year.
The Three Main Types and Their Frequency
SVT is an umbrella term covering several distinct rhythm problems. The breakdown matters because each type behaves a little differently:
- AVNRT (roughly 50 to 60% of cases): The electrical signal gets caught in a loop near the center of the heart. This is the most common type overall and the one most likely to affect women.
- AVRT (roughly 30% of cases): An extra electrical pathway connects the upper and lower chambers, creating a circuit. Wolff-Parkinson-White falls into this category.
- Atrial tachycardia (roughly 10% of cases): The rapid rhythm originates from a spot in one of the upper chambers. This is the least common form and also shows a female predominance.
Common Triggers
Most people with SVT notice that certain situations make episodes more likely. The most frequently reported triggers include alcohol, caffeine, exercise, and sleep deprivation. Stress and dehydration are also commonly cited. Interestingly, the relationship between caffeine and heart rhythm is more nuanced than most people assume. While caffeine can increase the frequency of premature heartbeats (one trial showed a 54% increase compared to caffeine-free controls), habitual coffee drinking has actually been associated with lower rates of some arrhythmias. For most SVT patients, tracking personal triggers through a symptom diary is more useful than following blanket advice about what to avoid.
Treatment Success and Recurrence
Catheter ablation, a procedure that uses heat or cold energy to disable the tiny area of heart tissue causing the abnormal rhythm, is considered the definitive treatment for SVT. Success rates are high, but recurrence still happens in roughly 10 to 15% of cases. The likelihood of recurrence depends partly on where the problem circuit sits. When the abnormal tissue is close to the heart’s normal electrical wiring, doctors sometimes deliberately leave small areas untreated to avoid damaging healthy pathways, which can increase the chance of the rhythm returning.
In the pediatric population, about one in five children diagnosed with SVT undergoes ablation before age 15, typically around age 11. The remaining 83% either manage with medication, outgrow their episodes (especially common in infants), or have symptoms infrequent enough that no procedure is needed.
For people who prefer not to have a procedure or whose episodes are rare, medications that slow electrical conduction through the heart can reduce episode frequency. Many people also learn vagal maneuvers, simple physical techniques like bearing down or applying cold water to the face, that can sometimes stop an episode within seconds.